These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 13269837)

  • 21. A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA.
    Aljurayyan AN; Sharma R; Upile N; Beer H; Vaughan C; Xie C; Achar P; Ahmed MS; McNamara PS; Gordon SB; Zhang Q
    Antiviral Res; 2016 Aug; 132():122-30. PubMed ID: 27247060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.
    Meier S; Bel M; L'huillier A; Crisinel PA; Combescure C; Kaiser L; Grillet S; Pósfay-Barbe K; Siegrist CA;
    Vaccine; 2011 Apr; 29(19):3548-57. PubMed ID: 21419775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eccentric exercise as an adjuvant to influenza vaccination in humans.
    Edwards KM; Burns VE; Allen LM; McPhee JS; Bosch JA; Carroll D; Drayson M; Ring C
    Brain Behav Immun; 2007 Feb; 21(2):209-17. PubMed ID: 16824730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.
    El Sahly H
    Expert Rev Vaccines; 2010 Oct; 9(10):1135-41. PubMed ID: 20923265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    HOBSON D; LANE CA; BEARE AS; CHIVERS CP
    Br Med J; 1964 Aug; 2(5404):271-4. PubMed ID: 14160207
    [No Abstract]   [Full Text] [Related]  

  • 27. Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.
    HENNESSY AV; DAVENPORT FM
    Public Health Rep (1896); 1961 May; 76(5):411-9. PubMed ID: 13713365
    [No Abstract]   [Full Text] [Related]  

  • 28. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of an adjuvant influenza virus vaccine tested against influenza B in 1954-1955.
    CRYNS WF; DAVENPORT FM; HENNESSY AV; HOUSER HB
    Am J Hyg; 1956 Nov; 64(3):304-13. PubMed ID: 13372524
    [No Abstract]   [Full Text] [Related]  

  • 30. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.
    Langley JM; Frenette L; Ferguson L; Riff D; Sheldon E; Risi G; Johnson C; Li P; Kenney R; Innis B; Fries L
    J Infect Dis; 2010 Jun; 201(11):1644-53. PubMed ID: 20423222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions.
    SALK JE; LAURENT AM
    J Exp Med; 1952 May; 95(5):429-47. PubMed ID: 14927797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses.
    Hilgers LAT; Platenburg PPLI; Bajramovic J; Veth J; Sauerwein R; Roeffen W; Pohl M; van Amerongen G; Stittelaar KJ; van den Bosch JF
    Vaccine; 2017 May; 35(24):3249-3255. PubMed ID: 28479181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.
    Luke CJ; Subbarao K
    Expert Rev Vaccines; 2014 Jul; 13(7):873-83. PubMed ID: 24855993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to influenza vaccine in people with non-protective HI antibody titers.
    Baldo V; Baldovin T; Floreani A; Minuzzo M; Trivello R
    Eur J Epidemiol; 2006; 21(11):843-5. PubMed ID: 17082899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
    Levie K; Leroux-Roels I; Hoppenbrouwers K; Kervyn AD; Vandermeulen C; Forgus S; Leroux-Roels G; Pichon S; Kusters I
    J Infect Dis; 2008 Sep; 198(5):642-9. PubMed ID: 18576945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects.
    Gasparini R; Schioppa F; Lattanzi M; Barone M; Casula D; Pellegrini M; Veitch K; Gaitatzis N
    Int J Clin Pract; 2010 Mar; 64(4):432-8. PubMed ID: 20039974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.